Ovarian Hormones as a Source of Fluctuating Biological Vulnerability in Borderline Personality Disorder.
Curr Psychiatry Rep
; 21(11): 109, 2019 10 17.
Article
in En
| MEDLINE
| ID: mdl-31624929
PURPOSE OF REVIEW: To examine the potential role of ovarian hormones in biological vulnerability to borderline personality disorder (BPD). The review focuses primarily on research examining the menstrual cycle as a source of short-term lability of BPD symptom expression, while discussing the currently understudied possibility of ovarian hormone influence in the developmental course of BPD. FINDINGS: Several patterns of menstrual cycle effects on BPD symptoms and relevant features in non-clinical samples have been observed in empirical studies. Most symptoms demonstrated patterns consistent with perimenstrual exacerbation; however, timing varied between high and low arousal symptoms, potentially reflecting differing mechanisms. Symptoms are typically lowest around ovulation, with an exception for proactive aggression and some forms of impulsive behaviors. Preliminary evidence suggests ovarian hormones may exert strong effects on BPD symptom expression, and further research is warranted examining mechanisms and developing interventions. Recommendations for researchers and clinicians working with BPD are provided.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Ovary
/
Borderline Personality Disorder
/
Gonadal Hormones
/
Menstrual Cycle
Type of study:
Guideline
Limits:
Female
/
Humans
Language:
En
Journal:
Curr Psychiatry Rep
Journal subject:
PSIQUIATRIA
Year:
2019
Document type:
Article
Affiliation country:
United States
Country of publication:
United States